219 related articles for article (PubMed ID: 31191516)
1. Inflammatory Phenotype of Intrahepatic Sulfatide-Reactive Type II NKT Cells in Humans With Autoimmune Hepatitis.
Sebode M; Wigger J; Filpe P; Fischer L; Weidemann S; Krech T; Weiler-Normann C; Peiseler M; Hartl J; Tolosa E; Herkel J; Schramm C; Lohse AW; Arrenberg P
Front Immunol; 2019; 10():1065. PubMed ID: 31191516
[No Abstract] [Full Text] [Related]
2. Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease.
Weng X; He Y; Visvabharathy L; Liao CM; Tan X; Balakumar A; Wang CR
J Hepatol; 2017 Oct; 67(4):791-800. PubMed ID: 28596110
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte.
Rhost S; Löfbom L; Rynmark BM; Pei B; Månsson JE; Teneberg S; Blomqvist M; Cardell SL
Eur J Immunol; 2012 Nov; 42(11):2851-60. PubMed ID: 22777932
[TBL] [Abstract][Full Text] [Related]
4. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice.
Arrenberg P; Maricic I; Kumar V
Gastroenterology; 2011 Feb; 140(2):646-55. PubMed ID: 20950612
[TBL] [Abstract][Full Text] [Related]
5. Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells.
Blomqvist M; Rhost S; Teneberg S; Löfbom L; Osterbye T; Brigl M; Månsson JE; Cardell SL
Eur J Immunol; 2009 Jul; 39(7):1726-35. PubMed ID: 19582739
[TBL] [Abstract][Full Text] [Related]
6. Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease.
Halder RC; Aguilera C; Maricic I; Kumar V
J Clin Invest; 2007 Aug; 117(8):2302-12. PubMed ID: 17641782
[TBL] [Abstract][Full Text] [Related]
7. [Sulfatide-loaded CD1d tetramer to detect typeII NKT cells in mice].
Zhang GQ; Nie HX; Yang J; Yu HY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jul; 28(7):696-8. PubMed ID: 22768857
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C.
Yanagisawa K; Yue S; van der Vliet HJ; Wang R; Alatrakchi N; Golden-Mason L; Schuppan D; Koziel MJ; Rosen HR; Exley MA
J Viral Hepat; 2013 Aug; 20(8):556-65. PubMed ID: 23808994
[TBL] [Abstract][Full Text] [Related]
9. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.
Dasgupta S; Kumar V
Immunogenetics; 2016 Aug; 68(8):665-76. PubMed ID: 27405300
[TBL] [Abstract][Full Text] [Related]
10. CD1d-Restricted Type II NKT Cells Reactive With Endogenous Hydrophobic Peptides.
Nishioka Y; Masuda S; Tomaru U; Ishizu A
Front Immunol; 2018; 9():548. PubMed ID: 29599785
[TBL] [Abstract][Full Text] [Related]
11. Detection of Autoreactive Type II NKT Cells: A Pilot Study of Comparison Between Healthy Individuals and Patients with Vasculitis.
Nishioka Y; Sonoda T; Shida H; Kusunoki Y; Hattanda F; Tanimura S; Uozumi R; Yamada M; Nishibata Y; Masuda S; Nakazawa D; Tomaru U; Atsumi T; Ishizu A
Cytometry A; 2018 Nov; 93(11):1157-1164. PubMed ID: 30253046
[TBL] [Abstract][Full Text] [Related]
12. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
[TBL] [Abstract][Full Text] [Related]
13. Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor.
Patel O; Pellicci DG; Gras S; Sandoval-Romero ML; Uldrich AP; Mallevaey T; Clarke AJ; Le Nours J; Theodossis A; Cardell SL; Gapin L; Godfrey DI; Rossjohn J
Nat Immunol; 2012 Sep; 13(9):857-63. PubMed ID: 22820603
[TBL] [Abstract][Full Text] [Related]
14. Autoreactivity to Sulfatide by Human Invariant NKT Cells.
Stax AM; Tuengel J; Girardi E; Kitano N; Allan LL; Liu V; Zheng D; Panenka WJ; Guillaume J; Wong CH; van Calenbergh S; Zajonc DM; van den Elzen P
J Immunol; 2017 Jul; 199(1):97-106. PubMed ID: 28526683
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice.
Maricic I; Sheng H; Marrero I; Seki E; Kisseleva T; Chaturvedi S; Molle N; Mathews SA; Gao B; Kumar V
Hepatology; 2015 Apr; 61(4):1357-69. PubMed ID: 25477000
[TBL] [Abstract][Full Text] [Related]
16. Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells.
Roy KC; Maricic I; Khurana A; Smith TR; Halder RC; Kumar V
J Immunol; 2008 Mar; 180(5):2942-50. PubMed ID: 18292516
[TBL] [Abstract][Full Text] [Related]
17. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.
Maricic I; Girardi E; Zajonc DM; Kumar V
J Immunol; 2014 Nov; 193(9):4580-9. PubMed ID: 25261475
[TBL] [Abstract][Full Text] [Related]
18. Sulfatide administration leads to inhibition of HIV-1 replication and enhanced hematopoeisis.
Sundell IB; Halder R; Zhang M; Maricic I; Koka PS; Kumar V
J Stem Cells; 2010; 5(1):33-42. PubMed ID: 20861926
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells and anergic type I NKT cells play a crucial role in sulfatide-mediated immune regulation in experimental autoimmune encephalomyelitis.
Maricic I; Halder R; Bischof F; Kumar V
J Immunol; 2014 Aug; 193(3):1035-46. PubMed ID: 24973441
[TBL] [Abstract][Full Text] [Related]
20. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis.
Chuang YH; Lian ZX; Yang GX; Shu SA; Moritoki Y; Ridgway WM; Ansari AA; Kronenberg M; Flavell RA; Gao B; Gershwin ME
Hepatology; 2008 Feb; 47(2):571-80. PubMed ID: 18098320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]